These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2874989)

  • 61. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of the anxiolytic activity of Nunavik Rhodiola rosea.
    Cayer C; Ahmed F; Filion V; Saleem A; Cuerrier A; Allard M; Rochefort G; Merali Z; Arnason JT
    Planta Med; 2013 Oct; 79(15):1385-91. PubMed ID: 23975866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
    Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V
    Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
    Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Radish, Raphanus sativus L. Var. caudatus reduces anxiety-like behavior in mice.
    Siddiq A; Younus I
    Metab Brain Dis; 2018 Aug; 33(4):1255-1260. PubMed ID: 29671209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preclinical study of anxiolytic activity and safety of Racium phytomedicine].
    Kravchenko EV; Nasek VM; Ponteleeva IV; Mazhar MV; Sholomitskaia EIu; Zhukova IA; San'ko EV; Veselukha OV; Nekhai AS; Shafranovskaia EV; Zhebrakova IV
    Eksp Klin Farmakol; 2012; 75(8):21-4. PubMed ID: 23012991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa.
    Sollozo-Dupont I; Estrada-Camarena E; Carro-Juárez M; López-Rubalcava C
    J Ethnopharmacol; 2015 Mar; 162():278-86. PubMed ID: 25582489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical study of the selective anxiolytic agent afobazol].
    Neznamov GG; Siuniakov SA; Chumakov DV; Bochkarev VK; Seredenin SB
    Eksp Klin Farmakol; 2001; 64(2):15-9. PubMed ID: 11548440
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical study of clobazam in patients with gastrointestinal disorders [proceedings].
    Laudano O
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):129S. PubMed ID: 35193
    [No Abstract]   [Full Text] [Related]  

  • 71. Anxiolytic, antidepressant, and antistress activities of the aqueous extract of
    Upadhyay G; Khoshla S; Kosuru R; Singh S
    Indian J Pharmacol; 2016; 48(5):555-561. PubMed ID: 27721543
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP; Kieser M
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
    Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
    Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Souroubea sympetala (Marcgraviaceae): a medicinal plant that exerts anxiolysis through interaction with the GABAA benzodiazepine receptor.
    Mullally M; Cayer C; Kramp K; Otárola Rojas M; Sanchez Vindas P; Garcia M; Poveda Alvarez L; Durst T; Merali Z; Trudeau VL; Arnason JT
    Can J Physiol Pharmacol; 2014 Sep; 92(9):758-64. PubMed ID: 25140794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic anxiolytic treatment: benefit and risk.
    Marks J
    Adv Biochem Psychopharmacol; 1985; 40():173-83. PubMed ID: 2862763
    [No Abstract]   [Full Text] [Related]  

  • 76. Anxiolytic effects of standardized extract of Centella asiatica (ECa 233) after chronic immobilization stress in mice.
    Wanasuntronwong A; Tantisira MH; Tantisira B; Watanabe H
    J Ethnopharmacol; 2012 Sep; 143(2):579-85. PubMed ID: 22841896
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice.
    Salkind MR; Hanks GW; Silverstone JT
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):113S-118S. PubMed ID: 35189
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.
    Lucki I; Rickels K; Giesecke MA; Geller A
    Br J Clin Pharmacol; 1987 Feb; 23(2):207-11. PubMed ID: 2881573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.
    Papadopoulos A; Rich A; Nutt DJ; Bailey JE
    J Psychopharmacol; 2010 May; 24(5):649-56. PubMed ID: 18832434
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of anxiety and depression: medicinal plants in retrospect.
    Fajemiroye JO; da Silva DM; de Oliveira DR; Costa EA
    Fundam Clin Pharmacol; 2016 Jun; 30(3):198-215. PubMed ID: 26851117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.